Roche’s Injectable Eye Medicine Lessens Treatment Burden in Two Diseases
On 12th February, Roche announced detailed results from four Phase 3 studies of its investigational bispecific antibody, faricimab, for the treatment of diabetic macular edema (DME) and neovascular or “wet” …
Read More